SE8901149D0 - AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT - Google Patents

AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT

Info

Publication number
SE8901149D0
SE8901149D0 SE8901149A SE8901149A SE8901149D0 SE 8901149 D0 SE8901149 D0 SE 8901149D0 SE 8901149 A SE8901149 A SE 8901149A SE 8901149 A SE8901149 A SE 8901149A SE 8901149 D0 SE8901149 D0 SE 8901149D0
Authority
SE
Sweden
Prior art keywords
cholecystokinin
pupill
oegat
agents
construction
Prior art date
Application number
SE8901149A
Other languages
Swedish (sv)
Inventor
A Bill
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8901149A priority Critical patent/SE8901149D0/en
Publication of SE8901149D0 publication Critical patent/SE8901149D0/en
Priority to EP19920113164 priority patent/EP0522596A1/en
Priority to PCT/SE1990/000219 priority patent/WO1990011773A1/en
Priority to CA002030525A priority patent/CA2030525A1/en
Priority to HU903583A priority patent/HU206185B/en
Priority to EP90906391A priority patent/EP0422181A1/en
Priority to AU54282/90A priority patent/AU627570B2/en
Priority to JP2506058A priority patent/JPH03505224A/en
Priority to NO90905069A priority patent/NO905069L/en
Priority to KR1019900702506A priority patent/KR920700044A/en
Priority to FI905952A priority patent/FI905952A0/en
Priority to SU904894239A priority patent/RU2003331C1/en
Priority to BG093398A priority patent/BG93398A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The use of cholecystokinin and derivatives of cholecystokinin for inducing miosis in the eye (pupil constriction) after certain types of examinations and operations. Furthermore, the use of antagonists to cholecystokinin and derivatives of these for preventing miosis in the eye, for example during surgery and in cases of uveitis. The invention moreover also comprises ophthalmological compositions containing an active amount of cholecystokinin or of its derivatives or antagonists.
SE8901149A 1989-04-03 1989-04-03 AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT SE8901149D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8901149A SE8901149D0 (en) 1989-04-03 1989-04-03 AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT
JP2506058A JPH03505224A (en) 1989-04-03 1990-04-03 Methods and means for respectively inducing or preventing constriction of the pupils of the eye
HU903583A HU206185B (en) 1989-04-03 1990-04-03 Process for producing pharmaceutical compositions suitable for causing or hindering pupillary contraction
PCT/SE1990/000219 WO1990011773A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
CA002030525A CA2030525A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
EP19920113164 EP0522596A1 (en) 1989-04-03 1990-04-03 Method and means for inducing constriction of the pupil in the eye
EP90906391A EP0422181A1 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
AU54282/90A AU627570B2 (en) 1989-04-03 1990-04-03 Method and means for inducing, resp., preventing constriction of the pupil in the eye
NO90905069A NO905069L (en) 1989-04-03 1990-11-22 PROCEDURE AND MEASURES FOR INDUCTION, RESP. PREVENTION OF PREVENTION OF THE PUPILL IN THE EYE.
KR1019900702506A KR920700044A (en) 1989-04-03 1990-11-23 Methods and means for inducing and preventing pupillary contraction of the eye
FI905952A FI905952A0 (en) 1989-04-03 1990-12-03 FOERFARANDE OCH MEDEL FOER INDUCERING ELLER FOERHINDRANDE AV SAMMANDRAGNING AV PUPILLEN I OEGAT.
SU904894239A RU2003331C1 (en) 1989-04-03 1990-12-03 Agent for controlling contraction of the pupils
BG093398A BG93398A (en) 1989-04-03 1990-12-06 METHOD AND MEANS FOR INDUCING AND, THEREFORE, PREVENTING PUPIL CONTRACTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901149A SE8901149D0 (en) 1989-04-03 1989-04-03 AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT

Publications (1)

Publication Number Publication Date
SE8901149D0 true SE8901149D0 (en) 1989-04-03

Family

ID=20375526

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901149A SE8901149D0 (en) 1989-04-03 1989-04-03 AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT

Country Status (10)

Country Link
EP (1) EP0422181A1 (en)
JP (1) JPH03505224A (en)
KR (1) KR920700044A (en)
AU (1) AU627570B2 (en)
BG (1) BG93398A (en)
CA (1) CA2030525A1 (en)
FI (1) FI905952A0 (en)
HU (1) HU206185B (en)
SE (1) SE8901149D0 (en)
WO (1) WO1990011773A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206237A (en) * 1991-05-14 1993-04-27 Merck & Co., Inc. Benzodiazepine analogs
US5185331A (en) * 1991-05-14 1993-02-09 Merck & Co., Inc. Triazolobenzodiazepines
US5210082A (en) * 1991-05-16 1993-05-11 Merck & Co., Inc. 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder
US5177071A (en) * 1991-06-17 1993-01-05 Merck & Co., Inc. 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder
SE9201425D0 (en) * 1992-05-06 1992-05-06 Kabi Pharmacia Ab METHOD AND MEANS FOR PREVENTING CONSTRICTION OF THE PUPIL IN THE EYE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400377A (en) * 1980-09-26 1983-08-23 Farmitalia Carlo Erba, S.P.A. Use of polypeptides as analgesic drugs
DK489683A (en) * 1982-10-27 1984-04-28 Amano Pharma Co Ltd PROCEDURE FOR PREPARING PEPTIDES
IT1179866B (en) * 1984-12-12 1987-09-16 Rotta Research Lab PHARMACEUTICALLY ACTIVE TRIPTOPHANE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1179894B (en) * 1984-12-27 1987-09-16 Rotta Research Lab PROGLUMIDE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR USE IN NEOPLASTIC AFFECTION THERAPY
IT1204430B (en) * 1986-01-10 1989-03-01 Alfio Bertolini PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE COLECISTOKININA-CERULINA GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULATORY INSUFFICIENCY
DD272653A1 (en) * 1987-02-09 1989-10-18 Akad Wissenschaften Ddr METHOD FOR PRODUCING NEW ANTAGONISTS OF CHOLECYSTOKININE

Also Published As

Publication number Publication date
CA2030525A1 (en) 1990-10-04
AU627570B2 (en) 1992-08-27
HU903583D0 (en) 1991-05-28
HUT55994A (en) 1991-07-29
BG93398A (en) 1993-12-24
FI905952A0 (en) 1990-12-03
WO1990011773A1 (en) 1990-10-18
KR920700044A (en) 1992-02-19
AU5428290A (en) 1990-11-05
EP0422181A1 (en) 1991-04-17
JPH03505224A (en) 1991-11-14
HU206185B (en) 1992-09-28

Similar Documents

Publication Publication Date Title
EA199900811A1 (en) COMPOSITION FOR OPHTHALMIC SURGICAL OPERATIONS (OPTIONS) AND METHOD FOR THEIR IMPLEMENTATION
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BRPI0113042B8 (en) compound of the formula or a physiologically acceptable solvate thereof, use thereof, pharmaceutical composition, pharmaceutical formulation, method of treating a human or animal subject with an inflammatory and/or allergic condition, and, process for preparing a compound or a solvate thereof
BR0213738A (en) Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
DE69521620T2 (en) USE OF 9-DEOXYPROSTAGLAND IN DERIVATIVES FOR TREATING GLAUCOMA
KR920019342A (en) Bone Disease Treatment
AR024233A1 (en) CCR5 MODULATING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, ITS USE IN MEDICINE.
ES2063354T3 (en) REINFORCEMENT AND SUPPORT DEVICE FOR THE RIGATORS 'LIGAMENT OF AN ARTICULATION OF A PERSON'S SHOULDER.
DE69521994D1 (en) COMPOSITIONS WHICH CONTAIN DNA DESTROYING AGENTS AND P53
IL94990A0 (en) Pharmaceutical compositions for the prophylaxis and/or treatment of prostatic diseases
ES2187719T3 (en) DIFLUOROPROSTAGLANDINAS DERIVATIVES AND ITS APPLICATION.
MX9203667A (en) SALTS OF BIS-DIMETOXIMETIL (TRIMETOXIBENCIL) QUINOLINO, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE319458T1 (en) MEDICAL COMPOSITIONS FOR TREATING EYE DISEASES
YU47116B (en) PROCEDURE FOR OBTAINING NEW N-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
ES2192832T3 (en) USE OF MACROLID COMPOUNDS TO TREAT GLAUCOMA.
UA35567C2 (en) Pharmaceutical preparation for treating patients with coagulation impairment, method for treatment, method for pharmaceutical manufacturing
FI972308A0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use
SE8901149D0 (en) AGENTS FOR INDUCTION RESPECTIVE PREVENTION OF PUPILL CONSTRUCTION IN OEGAT
BR9907715A (en) Ophthalmic composition / method for treating corneal injury and / or impaired corneal esthesia, dry eye syndrome, hypolarcrimation and use of an aldose reductase inhibitor
BR9712308A (en) Secondary cataract inhibitor
EE200100188A (en) Optically active pyridyl-4H-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
SE9201425D0 (en) METHOD AND MEANS FOR PREVENTING CONSTRICTION OF THE PUPIL IN THE EYE
ES2073391T3 (en) METHOD AND THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF BLOOD LOSS.
BR9706891A (en) Compound, medicine, pharmaceutical composition and cosmetic composition.
MC1930A1 (en) ANTIVIRAL PRODUCT